Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
406 Cr
Moderate Risk
29.1
30.8
0.2
1.9
154.85
98.00
Sales CAGR
1Y
-2.01%
3Y
—
5Y
—
10Y
—
Profit CAGR
1Y
189.26%
3Y
—
5Y
—
10Y
—
ROE
TTM
6.64%
3Y
5.33%
5Y
14.84%
10Y
—
ROCE
TTM
11.47%
3Y
15.07%
5Y
18.74%
10Y
—
Bearish
3
Neutral
6
Bullish
5
Bearish
15
Neutral
18
Bullish
13
Bearish
12
Neutral
12
Bullish
8
Market Cap
₹ 406 Cr
P/E
29.07
Performance
UNDER PERFORMER
Valuation
REASONABLE
Growth
STABLE
Profitability
MODERATE MARGIN
Technicals
Neutral
Risk
MODERATE RISK